@StephenLChan1

Professor at Department of Clinical Oncology in Hong Kong with research interest in HBP cancer

 Hong Kong
Joined May 2018
  • Tweets99
  • Following73
  • Followers249
1Media
Stephen L. Chan retweeted
Daneng Li@DanengLiJan 9
keynote 937 negative study for adjuvant #HCC in line with prior results from IMbrave 050. Unfortunately, still lack of positive #HCC trials. Novel strategies needed since given uniqueness of HCC adjuvant population and underlying cirrhosis. #GI26 @ASCO
8
1
22
3,688
Stephen L. Chan retweeted
Jordi Bruix@bruixj25 Nov 2025
A webinar to comment the Lancet Commission paper about liver cancer takes place on Thursday. We will comment geographic differences to be solved in order to secure access to effective treatments, as well as research challenges to be tackled . link hubs.li/Q03GK-R30
3
1
17
627
Proud and honored to be part of @TheLancet Commission on #livercancer #HCC led by @StephenLChan1. @HUNIMED @HumanitasMilano 3 Out of 5 Liver Cancer Cases Are Preventable, Study Finds nytimes.com/2025/07/28/well/… via @NYTimes

3 Out of 5 Liver Cancer Cases Are Preventable, Study Finds (Published 2025)

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could nearly double by 2050.

nytimes.com
4
12
796
Incredibly proud to be part of @TheLancet Commission on #HCC! @StephenLChan1 @HUNIMED @HumanitasMilano
The Lancet
@TheLancet28 Jul 2025
The global burden of liver cancer is increasing. 📈 Hepatocellular carcinoma (HCC) accounts for approximately 80% of cases globally. 💡 A new Commission outlines evidence-based recommendations for action to reduce the global HCC burden: hubs.li/Q03yJtvJ0
Promotional card for The Lancet Commission on hepatocellular carcinoma. Background image depicts a computer-generated illustration of a human torso with an inflamed liver.

ALT Promotional card for The Lancet Commission on hepatocellular carcinoma. Background image depicts a computer-generated illustration of a human torso with an inflamed liver.

6
21
1,198
Stephen L. Chan retweeted
LARVOL
@Larvol22 Mar 2025
The FDA has issued a second rejection for the approval of rivoceranib plus camrelizumab as a first-line treatment for unresectable HCC. Here is the updated tracker of upcoming PDUFA dates and latest FDA approvals in oncology! Access real-time market intelligence and latest oncology insights with @Larvol PULSE. Check out the past FDA approvals: bit.ly/4iO7h1P #LARVOL #CancerResearch #PDUFA #Oncology #CancerData #ClinicalTrials #OncologyInsight Engage with the top voices on X discussing the latest PDUFA updates: @ArndtVogel | @StephenVLiu | @CathyEngMD | @AaronGoodman33 | @neerajaiims | @PGrivasMDPhD | @DrMLChua | @YJanjigianMD | @agz_eriksson | @SuyogCancer
20
1
41
5,046
Stephen L. Chan retweeted
Valerie Chew@Valeriechew2918 Oct 2024
Congratulations to the new #ilca #presidentelect @StephenLChan1 👏👏👏 – at Toronto, Ontario
1
4
29
1,597
We are thrilled to announce Prof. Vlad Ratziu as the new Editor-in-Chief of @JHepatology, starting January 2025! Joining him: ➡️Deputy Editors: @docberza & Frank Tacke ➡️Co-Editors: Tom H. Karlsen, @LorenzaRimassa, & @HeinerWedemeyer ➡️Senior Editor: Philip Newsome @EASLnews
https://bit.ly/45N7Mnk

ALT https://bit.ly/45N7Mnk

4
11
3
85
7,372
Stellar ⭐️ panel at @myESMO GI 2024 @LorenzaRimassa @StephenLChan1 @ma5RN discussing management of #HCC 💪
3
14
960
Stephen L. Chan retweeted
CUHK Medicine
@CUHKMedicine10 Apr 2024
In the QS Ranking by Subject 2024 @worlduniranking, @CUHKMedicine is ranked 1st in #HongKong, 2nd in #Asia and 28th globally this year, while our Nursing School @cuhknursing is the top spot both in #HongKong and #Asia and holds the 8th position globally. Details (Medicine): topuniversities.com/universi… Details (Nursing): topuniversities.com/universi…
3
21
2
52
7,358
The strong #HongKong 🇭🇰 contingent in #ESMOAsia23 ! @TonyMok9 @mollylisc @AyaHelali – at Central Region, Singapore
2
4
1
34
6,894
Stephen L. Chan retweeted
Landon Chan@LandonLChan2 Dec 2023
Happy to share my *first* poster in international conference on the recurrence pattern of HCC following curative surgery and RFA in the era of effective antivirals! Thx for the support! @StephenLChan1 @mollylisc @TonyMok9
4
1
20
1,396
Great discussion at the session on early drug development in GI cancers #ESMOAsia23 @myESMO @StephenLChan1 @CUHKMedicine
1
7
544
Stephen L. Chan retweeted
Landon Chan@LandonLChan2 Dec 2023
Excellent talks on unresolved issues and future directions on BTC/HCC/GEC/GC in ESMO ASIA 2023! @StephenLChan1 @LizzySmyth1 Dr. Do-Youn Oh
3
6
1,005
Stephen L. Chan retweeted
Landon Chan@LandonLChan30 Nov 2023
My dearest friend @mollylisc suggested to me to start using X Happy to share this mini-review on the inaugural issue of ESMO gastrointestinal oncology on our views on neoadjuvant immunotherapy for HCC! @StephenLChan1 @MissJanetKung sciencedirect.com/science/ar…
2
3
7
908
Replying to @StephenLChan1
@StephenLChan1 addressing the challenging topic of personalized treatment for patients with #HCC at #ESMO23 @DrAngelaLamarca @JDekervel @ArndtVogel @myESMO – at Madrid, Spain
7
1
18
7,882
Ready for the #ESMO23 hepatobiliary session? Immunotherapy and molecularly targeted agents for #HCC and #CCA @DrAngelaLamarca @JDekervel @ArndtVogel @StephenLChan1 @myESMO – at Madrid, Spain
4
23
997
Huge THANK YOU to all speakers @LorenzaRimassa @ArndtVogel @StephenLChan1 and my co-chair @JDekervel for your expertise in this session today. We hopefully leave #ESMO23 convinced that #biopsies are the way forward to bring #PrecisionMedicine to #HCC 😉🧬 @myESMO
Lorenza Rimassa@LorenzaRimassa23 Oct 2023
Replying to @StephenLChan1
@StephenLChan1 addressing the challenging topic of personalized treatment for patients with #HCC at #ESMO23 @DrAngelaLamarca @JDekervel @ArndtVogel @myESMO
3
5
1
41
5,045
Replying to @ArndtVogel
@ArndtVogel presenting and discussing #immunotherapy for patients with advanced #HCC at #ESMO23 @DrAngelaLamarca @JDekervel @StephenLChan1 @myESMO – at Madrid, Spain
2
1
12
1,175
How to improve quality of life #QOL of patients with #pancreatic cancer: jaundice, pain and ascites management, nutrition, exercise, radiotherapy #ESMO23 @StephenLChan1 @RadkaObermanno1 @ldawsonmd @myESMO – at Madrid, Spain
4
10
3,124
Hot off the press! 🔥 Findings of the CARES-310 now out in @TheLancet with our very own Prof @StephenLChan1 @CUHKMedicine as co-first author sciencedirect.com/science/ar…
1
4
13
1,773
Load more